Literature DB >> 30610060

IL13-Mediated Dectin-1 and Mannose Receptor Overexpression Promotes Macrophage Antitumor Activities through Recognition of Sialylated Tumor Cells.

Mohamad Alaeddine1, Mélissa Prat1, Véréna Poinsot2, Valérie Gouazé-Andersson1, Hélène Authier1, Etienne Meunier1, Lise Lefèvre1, Camille Alric1, Christophe Dardenne1, José Bernad1, Laurent Alric1, Bruno Segui3, Patricia Balard4, François Couderc2, Bettina Couderc3, Bernard Pipy1, Agnès Coste5.   

Abstract

Macrophage-mediated cytotoxicity is controlled by surface receptor expression and activation. Despite the numerous studies documenting the role of macrophage C-type lectin receptors (CLR) in pathogen elimination, little is known about their contribution to antitumor responses. Here, we report that IL13 inhibits T-cell lymphoma and ovarian adenocarcinoma development in tumor-bearing mice through the conversion of tumor-supporting macrophages to cytotoxic effectors, characterized by a CLR signature composed of dectin-1 and mannose receptor (MR). We show that dectin-1 and MR are critical for the recognition of tumor cells through sialic acid-specific glycan structure on their surface and for the subsequent activation of macrophage tumoricidal response. Finally, we validated that IL13 antitumor effect mediated by dectin-1 and MR overexpression on macrophages can extend to various types of human tumors. Therefore, these results identify these CLRs as potential targets to promote macrophage antitumor response and represent an attractive approach to elicit tumor-associated macrophage tumoricidal properties. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30610060     DOI: 10.1158/2326-6066.CIR-18-0213

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  7 in total

Review 1.  Diversity, Mechanisms, and Significance of Macrophage Plasticity.

Authors:  Massimo Locati; Graziella Curtale; Alberto Mantovani
Journal:  Annu Rev Pathol       Date:  2019-09-17       Impact factor: 23.472

2.  Comprehensive Analysis and Identification of an Immune-Related Gene Signature with Prognostic Value for Prostate Cancer.

Authors:  Yongrui Zhang; Yaowen Fu
Journal:  Int J Gen Med       Date:  2021-06-28

3.  Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity.

Authors:  Pengdou Zheng; Huojun Zhang; Weiling Jiang; Lingling Wang; Lu Liu; Yuhao Zhou; Ling Zhou; Huiguo Liu
Journal:  Front Mol Biosci       Date:  2022-04-11

4.  Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib.

Authors:  Damian Mikulski; Paweł Robak; Ewelina Perdas; Edyta Węgłowska; Aleksandra Łosiewicz; Izabela Dróżdż; Dariusz Jarych; Małgorzata Misiewicz; Janusz Szemraj; Wojciech Fendler; Tadeusz Robak
Journal:  J Clin Med       Date:  2021-12-26       Impact factor: 4.241

Review 5.  Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer.

Authors:  Chunxiao Li; Xiaofei Xu; Shuhua Wei; Ping Jiang; Lixiang Xue; Junjie Wang
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 12.469

Review 6.  Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors.

Authors:  Lilong Zhang; Dongqi Chai; Chen Chen; Chunlei Li; Zhendong Qiu; Tianrui Kuang; Mungur Parveena; Keshuai Dong; Jia Yu; Wenhong Deng; Weixing Wang
Journal:  Front Microbiol       Date:  2022-07-13       Impact factor: 6.064

7.  Comparative study of the effects of ziram and disulfiram on human monocyte-derived macrophage functions and polarization: involvement of zinc.

Authors:  Melissa Parny; José Bernad; Mélissa Prat; Marie Salon; Agnès Aubouy; Elsa Bonnafé; Agnès Coste; Bernard Pipy; Michel Treilhou
Journal:  Cell Biol Toxicol       Date:  2020-07-25       Impact factor: 6.691

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.